Last reviewed · How we verify

NCT07158073

Effect of ORI-guided Oxygen Titration on Oxidative Stress in Rhinoplasty Surgery

Completed NA Last updated 8 September 2025
What this trial tests

NA trial testing FiO₂ titration, under the guidance of ORI in Rhinoplasty in 60 participants. Completed in 30 August 2021.

Timeline
1 March 2021
Primary endpoint
20 August 2021
30 August 2021

Quick facts

Lead sponsorDr. Lutfi Kirdar Kartal Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment60
Start date1 March 2021
Primary completion20 August 2021
Estimated completion30 August 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Who can join

18 and older, any sex, with Rhinoplasty or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate whether the use of Oxygen Reserve Index (ORİ) can prevent hyperoxia in patients undergoing rhinoplasty surgery and whether it can reduce oxidative stress caused by hyperoxia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of oxygen reserve index guided oxygen titration on oxidative stress in rhinoplasty surgery: a randomized controlled trial.
    Karakaşoğlu R, Geyik FD, Çevik BE, Saraçoğlu KT. · · 2025 · PMID 41188744 · DOI 10.1186/s12871-025-03424-0

Verify or expand the search:

Other recruiting trials for Rhinoplasty

Currently open trials in the same condition.

Other Dr. Lutfi Kirdar Kartal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07158073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing